We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing (VoriTDM)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01416025
First Posted: August 12, 2011
Last Update Posted: August 18, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Pfizer
Information provided by (Responsible Party):
Kieren Marr, Johns Hopkins University
Results First Submitted: April 15, 2016  
Study Type: Interventional
Study Design: Allocation: Randomized;   Intervention Model: Parallel Assignment;   Masking: None (Open Label);   Primary Purpose: Treatment
Condition: Fungal Infection
Intervention: Drug: Prospective TDM Arm

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Prospective TDM Arm

Voriconazole dose will be adjusted based on per protocol obtained TDM levels

Prospective TDM Arm: Voriconazole dose will be adjusted based on per protocol obtained TDM levels

Standard Dosing Standard doses of voriconazole will be used

Participant Flow:   Overall Study
    Prospective TDM Arm   Standard Dosing
STARTED   14   15 
COMPLETED   14   15 
NOT COMPLETED   0   0 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
  Description
Prospective TDM Arm

Voriconazole dose will be adjusted based on per protocol obtained TDM levels

Prospective TDM Arm: Voriconazole dose will be adjusted based on per protocol obtained TDM levels

Standard Dosing Standard doses of voriconazole will be used
Total Total of all reporting groups

Baseline Measures
   Prospective TDM Arm   Standard Dosing   Total 
Overall Participants Analyzed 
[Units: Participants]
 14   15   29 
Age 
[Units: Participants]
     
<=18 years   0   0   0 
Between 18 and 65 years   10   10   20 
>=65 years   4   5   9 
Age 
[Units: Years]
Mean (Full Range)
 63.4 
 (49 to 83) 
 59.1 
 (28 to 84) 
 62.5 
 (28 to 84) 
Gender 
[Units: Participants]
     
Female   5   5   10 
Male   9   10   19 
Region of Enrollment 
[Units: Participants]
     
United States   14   15   29 


  Outcome Measures

1.  Primary:   Number of Participants With Treatment Failure   [ Time Frame: 42 days ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: Dr. Darin Ostrander
Organization: JohnHopkinsU
phone: (443) 287-6217
e-mail: dostrander@jhu.edu



Responsible Party: Kieren Marr, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT01416025     History of Changes
Other Study ID Numbers: NA_00041916
First Submitted: August 11, 2011
First Posted: August 12, 2011
Results First Submitted: April 15, 2016
Results First Posted: May 23, 2016
Last Update Posted: August 18, 2016



To Top